Episode 22 – Rapid Fire with Dr. Hughes and Dr. Quinn

Welcome back Rounds Table Listeners!

Dr. Emily Hughes and Dr. Kieran Quinn are back today with our Classic Rapid Fire format! 4 papers…here we go!
1. Does the use of a remote monitoring system lower the risk of dying within 30 days in patients at high risk of clinical deterioration? (0:40 – 7:40)

2. Does a once-weekly basal insulin analogue (icodec) have similar glycemic control to once-daily glargine U100 in patients with T2D with inadequate control not previously on insulin? (7:03 – 13:50)

3a. How did patterns of care delivery change during the COVID-19 pandemic? (13:50 – 20:50)

3b. What types of patients felt unprepared to used telemedicine during the COVID-19 pandemic? (13:50 – 20:50)

4. What is the safety and efficacy of the SGLT2 inhibitor sotagliflozin in reducing hospitalization and death from cardiovascular causes when initiated soon after an episode of decompensated heart failure? (20:50 – 29:35)

Questions? Comments? Feedback? We’d love to hear from you. @roundstable